Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study-Reference-Cited by-同舟云学术

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study

Published:2019-10-14 Issue:7 Volume:38 Page:1735-1740
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Ploussard Guillaume^ORCID,Beauval Jean-Baptiste,Lesourd Marine,Manceau Cécile,Almeras Christophe,Aziza Richard,Gautier Jean-Romain,Loison Guillaume,Portalez Daniel,Salin Ambroise,Tollon Christophe,Soulié Michel,Malavaud Bernard,Roumiguié Mathieu

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02973-7.pdf

Reference27 articles.

1. Mottet N, Bellmunt J, Bolla M et al (2017) EAU–ESTRO–SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629

2. Loeb S, Berglund A, Stattin P (2013) Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer. J Urol 190:1742–1749

3. Balakrishnan AS, Cowan JE, Cooperberg MR et al (2019) Evaluating the safety of active surveillance: outcomes of deferred radical prostatectomy after an initial period of surveillance. J Urol. https://doi.org/10.1097/JU.00247

4. Kornberg Z, Cowan JE, Westphalen AC et al (2019) Genomic prostate score, PI-RADS™ version 2 and progression in men with prostate cancer on active surveillance. J Urol 201:300–307

5. Loeb S, Folkvaljon Y, Makarov DV, Bratt O, Bill-Axelson A, Stattin P (2015) Five-year nationwide follow-up study of active surveillance for prostate cancer. Eur Urol 67:233–238

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis;European Urology Oncology;2023-08

2. Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance;The Prostate;2023-05-12

3. Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis;Scandinavian Journal of Urology;2023-01-23

4. Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?;Journal of Urology;2021-04

5. MRI-guided active surveillance in prostate cancer: not yet ready for practice;Nature Reviews Urology;2020-12-11